# EAVE II Analysis Repository
## COVID-19 2nd dose vaccine waning 

### Paper Details
#### First dose
> **Title:** Two-dose ChAdOx1 vaccine protection against SARS-CoV-2 symptomatic infections, and COVID-19 hospitalisations and deaths over time: Population-based cohort studies in Scotland and Brazil
>
>**DOI:** [Insert DOI of paper here]
>
>**Paper authors:** Prof. Srinivasa Vittal Katikireddi, Thiago Cerqueira-Silva, Eleftheria Vasileiou, Prof. Chris Robertson, PhD* [2,6], Sarah Amele, PhD, Jiafeng Pan et al

### Funding
This analysis is part of the Early Assessment of COVID-19 epidemiology and Vaccine/anti-viral Effectiveness (EAVE II) study. EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through the Scottish Government DG Health and Social Care.  
[Insert any other funding information on paper here]
